Hyperfine, Inc.

US$0.72As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:HYPRHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (36.74%)
Div yield —
ROE (96.97%)
Medical Devices
Beta (5Y) 1.50
PE TTM —
TSR TTM (35.76%)
Mkt cap US$76.30M
ROIC (49.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.933
29.66%
48.56%
Hold 3|11|7|12|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.02
0.02
0.02
34.81%
36.84%
35.48%
34.82%
Revenue$M
10.13
10.48
10.92
10.93
10.59%
9.60%
11.92%
10.03%
Peers (US$76.30M)
Cap (US$)
PE
76.16M
23.43x
Capital
TTM
5Y
10Y
Leveragex
1.351
0.050
0.046
EBIT/Intx
2.002
0.290
0.206
Own earn%
(105.24)
(195.22)
(191.34)
Sh yield%
31.18
24.58
26.88
Owners
Insiders/Inst%
9.40
83.77
Short interest%
3.37
SBC / revenue%
2.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
3–9
$1 testx
—
Incr. ROIC%
16